IONS
IONS
NASDAQ · Biotechnology

Ionis Pharmaceuticals Inc

$38.80
-1.35 (-3.36%)
Analyst Consensus
Strong Buy
31
Analysts
Very High
Coverage
Buy 25 81%
Hold 6 19%
Sell 0 0%
Price Target
Analyst Price Target +93.1% upside
Low Target $58.43
Average Target $74.94
High Target $113.95
Current Price $38.80
Current
$38.80
Target
$74.94
$58.43 $74.94 avg $113.95
Scenario Analysis
Bear Case
$58.43
50.6%
Low target
Base Case
$74.94
+93.1%
Avg target
Bull Case
$113.95
+193.7%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$86.74
-55.3% from high
52-Week Low
$42.08
+-7.8% from low
50-Day SMA
$47.75
-18.7% vs SMA
200-Day SMA
$66.24
-41.4% vs SMA
RSI (14)
34.5
Neutral
Target vs 52W High
$74.94
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -35.8%